Nu-Med Plus (NUMD) Interest Expenses (2012 - 2025)
Nu-Med Plus (NUMD) reported Interest Expenses of $2857.0 for Q4 2025, up 126.57% on a YoY basis from $1261.0 in Q4 2024, and up 51.08% sequentially from $1891.0 in Q3 2025.
Nu-Med Plus (NUMD) Interest Expenses (2012 - 2025) Analysis & Trends
Nu-Med Plus (NUMD) has 14 years of Interest Expenses data on file, last reported at $2857.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest Expenses rose 126.57% year-over-year to $2857.0; the trailing twelve-month figure through Dec 2025 stood at $7227.0 (up 44.11% YoY), and the FY2025 full-year result was $2.3 million, up 0.63% from the prior year.
- Interest Expenses climbed to $2857.0 in Q4 2025, from $1891.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $2.1 million in Q4 2021 to a low of $1233.0 in Q1 2023.
- A 5-year average of $297217.2 and a median of $1260.0 in 2023 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses soared 93532.93% in 2021 and sank 99.94% in 2023, its largest moves.
- Tracing NUMD's Interest Expenses over 5 years: stood at $2.1 million in 2021, then decreased by 0.11% to $2.1 million in 2022, then slumped by 99.94% to $1260.0 in 2023, then advanced by 0.08% to $1261.0 in 2024, then surged by 126.57% to $2857.0 in 2025.
- Business Quant data shows NUMD's Interest Expenses at $2857.0 in Q4 2025, $1891.0 in Q3 2025, and $1246.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 400.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -97.17 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -140.00 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 2,857.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,857.00 |
| Dec 31, 2025 | 2,857.00 |
| Sep 30, 2025 | 1,891.00 |
| Sep 30, 2025 | 1,891.00 |
| Jun 30, 2025 | 1,246.00 |
| Jun 30, 2025 | 1,246.00 |
| Mar 31, 2025 | 1,233.00 |
| Mar 31, 2025 | 1,233.00 |
| Dec 31, 2024 | 1,261.00 |
| Dec 31, 2024 | 1,261.00 |
| Sep 30, 2024 | 1,260.00 |
| Sep 30, 2024 | 1,260.00 |
| Jun 30, 2024 | 1,247.00 |
| Jun 30, 2024 | 1,247.00 |
| Mar 31, 2024 | 1,247.00 |
| Mar 31, 2024 | 1,247.00 |
| Dec 31, 2023 | 1,260.00 |
| Dec 31, 2023 | 1,260.00 |
| Sep 30, 2023 | 1,260.00 |
| Sep 30, 2023 | 1,260.00 |